{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:29:40Z","timestamp":1786368580879,"version":"build-2736575974"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>\n                    Propofol, one of the most widely used intravenous anesthetics, is undergoing a transformative identity shift from a purely surgical agent to a potential therapeutic tool for neuropsychiatric disorders. This review synthesizes current evidence on the emerging field of propofol therapeutics, with a focus on its rapid antidepressant, anti-anhedonia, and anxiolytic effects. We first examine preliminary clinical evidence from open-label studies suggesting that propofol may produce dose-dependent mood-elevating effects in treatment-resistant depression; however, this evidence remains limited by small sample sizes and lack of large controlled trials. Next, we explore putative mechanisms, including GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor modulation, dopamine transporter inhibition, BDNF\/TrkB signaling, and network-level reorganization of the default mode network and sleep architecture. We then compare propofol with other anesthetic agents possessing antidepressant properties, particularly ketamine, highlighting their distinct receptor targets, efficacy profiles, and safety considerations. Finally, we discuss major challenges including optimal dosing strategies, tolerance with repeated administration, long-term safety concerns, and implementation barriers. Despite these challenges, propofol represents a promising candidate for anesthetic repurposing in psychiatry, offering a mechanistically distinct alternative to ketamine that targets both GABAergic and dopaminergic systems with a well-established clinical safety profile for surgical anesthesia.\n                  <\/jats:p>","DOI":"10.3389\/fphys.2026.1876988","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:44:23Z","timestamp":1786365863000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Propofol for depression: mechanisms and therapeutic potential"],"prefix":"10.3389","volume":"17","author":[{"given":"Dan","family":"Yu","sequence":"first","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liao","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqiu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Meng","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Gong","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]},{"name":"Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1515\/revneuro-2020-0001","article-title":"The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence","volume":"31","author":"Al-Alawi","year":"2020","journal-title":"Rev. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/17450179-v19-230823-2023-4","article-title":"Dexmedetomidine in the treatment of depression: An up-to-date narrative review","volume":"19","author":"Al-Mahrouqi","year":"2023","journal-title":"Clin. Pract. Epidemiol Ment. Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146021","article-title":"GABRB2, a key player in neuropsychiatric disorders and beyond","volume":"809","author":"Barki","year":"2022","journal-title":"Gene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"B6","first-page":"599","article-title":"Psycho-mimetic manifestations following propofol in day care surgery--case reports","volume":"20","author":"Bhakta","year":"2010","journal-title":"Mid East J. Anaesthesiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-neuro-112723-062031","article-title":"Anesthetics as treatments for depression: clinical insights and underlying mechanisms","volume":"48","author":"Breault","year":"2025","journal-title":"Annu. Rev. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00124509-200403000-00002","article-title":"Propofol reduces cognitive impairment after electroconvulsive therapy","volume":"20","author":"Butterfield","year":"2004","journal-title":"J. ECT"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/ndt.s463028","article-title":"Comparison of effects of propofol combined with different doses of esketamine for ECT in the treatment of depression: a randomized controlled trial protocol","volume":"20","author":"Chen","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clinph.2022.08.003","article-title":"Altered functional and directed connectivity in propofol-induced loss of consciousness: A source-space resting-state EEG study","volume":"142","author":"Chen","year":"2022","journal-title":"Clin. Neurophysiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107778","article-title":"Three classes of propofol binding sites on GABA(A) receptors","volume":"300","author":"Chen","year":"2024","journal-title":"J. Biol. Chem."},{"key":"B12","first-page":"359","article-title":"Propofol and methohexitone anaesthesia: effects on the profile of mood state","volume":"11","author":"D'Haese","year":"1994","journal-title":"Eur. J. Anaesthesiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1503\/jpn.150223","article-title":"Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy","volume":"41","author":"Dubin","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1039\/d5em00061k","article-title":"Updated global warming potentials of inhaled halogenated anesthetics, isoflurane and sevoflurane from new temperature dependent OH-kinetics","volume":"27","author":"Espinosa","year":"2025","journal-title":"Environ. Sci. Proc Impacts"},{"key":"B18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00213-024-06699-2","article-title":"Immediate effects of propofol on mood: a randomized comparison of two doses in a cohort with depression","volume":"242","author":"Feldman","year":"2025","journal-title":"Psychopharmacol. (Berl)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/ccm.0b013e318180c1eb","article-title":"Predictors of mortality in patients with suspected propofol infusion syndrome","volume":"36","author":"Fong","year":"2008","journal-title":"Crit. Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nrn2372","article-title":"General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal","volume":"9","author":"Franks","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/00124509-200112000-00009","article-title":"Inefficacy of burst-suppression anesthesia in medication-resistant major depression: a controlled trial","volume":"17","author":"Garcia-Toro","year":"2001","journal-title":"J. ECT"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106023","article-title":"Nitrous oxide for the treatment of depression: a systematic review and meta-analysis","volume":"122","author":"Gill","year":"2025","journal-title":"EBioMedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.annemergmed.2007.12.002","article-title":"Barriers to propofol use in emergency medicine","volume":"52","author":"Green","year":"2008","journal-title":"Ann. Emerg. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/bja\/aex257","article-title":"Brain functional connectivity differentiates dexmedetomidine from propofol and natural sleep","volume":"119","author":"Guldenmund","year":"2017","journal-title":"Br. J. Anaesth"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70407","article-title":"Association of dexmedetomidine with postoperative depressive symptoms in older surgical patients: A prospective multicenter study","volume":"31","author":"Hao","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"B26","first-page":"217","article-title":"Anesthesia for electroconvulsive therapy: propofol versus thiopental","volume":"27","author":"Harti","year":"2001","journal-title":"Encephale"},{"key":"B27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","article-title":"Propofol infusion syndrome: a structured literature review and analysis of published case reports","volume":"122","author":"Hemphill","year":"2019","journal-title":"Br. J. Anaesth"},{"key":"B28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/yct.0b013e31815bfe2a","article-title":"Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review","volume":"24","author":"Hooten","year":"2008","journal-title":"J. ECT"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/aas.70083","article-title":"Propofol versus methohexital in electroconvulsive therapy: impact on treatment efficacy and adverse effects. A systematic literature review and meta-analysis","volume":"69","author":"Huoponen","year":"2025","journal-title":"Acta Anaesthesiol Scand."},{"key":"B30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-scale network dysfunction in major depressive disorder: A meta-analysis of resting-state functional connectivity","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1017\/s0033291797005564","article-title":"Relationship of seizure duration to antidepressant efficacy in electroconvulsive therapy","volume":"27","author":"Kales","year":"1997","journal-title":"Psychol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"712","DOI":"10.12688\/f1000research.24567.2","article-title":"Case report: Sustained mitochondrial damage in cardiomyocytes in patients with severe propofol infusion syndrome","volume":"9","author":"Karasawa","year":"2020","journal-title":"F1000Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1017\/s1461145709990587","article-title":"Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression","volume":"13","author":"Karolewicz","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/nejmp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/00000542-200604000-00021","article-title":"Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons","volume":"104","author":"Kingston","year":"2006","journal-title":"Anesthesiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1176\/appi.ajp.2010.10091293","article-title":"Propofol addiction initiated by anesthetic use","volume":"168","author":"Koopmann","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13054-015-1112-5","article-title":"Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports","volume":"19","author":"Krajcova","year":"2015","journal-title":"Crit. Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"key":"B39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.13004\/kjnt.2023.19.e4","article-title":"Comparison of midazolam and propofol infusion to suppress stress response in patients with severe traumatic brain injury: A prospective, randomized controlled trial","volume":"19","author":"Kurni","year":"2023","journal-title":"Korean J. Neurotrauma"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154098","article-title":"The incidence of propofol infusion syndrome in critically-ill patients","volume":"71","author":"Li","year":"2022","journal-title":"J. Crit. Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1692751","article-title":"Novel and emerging anesthetic drugs for the treatments of major depression: a comprehensive review of efficacy, mechanism, and outlook","volume":"16","author":"Li","year":"2025","journal-title":"Front. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s587487","article-title":"Effects of intraoperative esketamine-dexmedetomidine combination on postpartum depressive symptoms and neuropsychiatric events following cesarean delivery: A randomized controlled trial","volume":"20","author":"Li","year":"2026","journal-title":"Drug Des. Devel Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1056\/nejmct075234","article-title":"Electroconvulsive therapy for depression","volume":"357","author":"Lisanby","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/nrr.nrr-d-24-00828","article-title":"Dual effects of GABA A R agonist anesthetics in neurodevelopment and vulnerable brains: From neurotoxic to therapeutic effects","volume":"21","author":"Lu","year":"2026","journal-title":"Neural Regener. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10877-023-00986-7","article-title":"Clinical validation of an adapted Eleveld model for high-dose propofol treatments for depression","volume":"37","author":"Lybbert","year":"2023","journal-title":"J. Clin. Monit. Comput."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.153007","article-title":"Association of endogenous hormones with major depressive disorder phenotype: A systematic review and meta-analysis of drug-free case and control cross-sectional study","volume":"793","author":"Machahary","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.biopsych.2009.10.027","article-title":"Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies","volume":"67","author":"Maciag","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.encep.2016.02.004","article-title":"Depression","volume":"407","author":"Malhi","year":"2026","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.encep.2016.02.004","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejphar.2014.05.053","article-title":"Propofol selectively alters GluA1 AMPA receptor phosphorylation in the hippocampus but not prefrontal cortex in young and aged mice","volume":"738","author":"Mao","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpsychires.2015.01.003","article-title":"A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability","volume":"62","author":"McGirr","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/ijnp\/pyy085","article-title":"Propofol for treatment-resistant depression: a pilot study","volume":"21","author":"Mickey","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111386","article-title":"Beyond surgery: repurposing anesthetics for treatment of central nervous system disorders","volume":"139","author":"Mielko","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol Biol. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1553-2712.2010.00776.x","article-title":"Randomized clinical trial of propofol versus ketamine for procedural sedation in the emergency department","volume":"17","author":"Miner","year":"2010","journal-title":"Acad. Emerg. Med."},{"key":"B57","first-page":"960","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"389","author":"Movahed","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/sleep\/34.3.283","article-title":"Propofol anesthesia and sleep: a high-density EEG study","volume":"34","author":"Murphy","year":"2011","journal-title":"Sleep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biopsych.2014.11.016","article-title":"Nitrous oxide for treatment-resistant major depression: A proof-of-concept trial","volume":"78","author":"Nagele","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe1376","article-title":"A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression","volume":"13","author":"Nagele","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/npp.2013.2","article-title":"Fluoxetine-induced cortical adult neurogenesis","volume":"38","author":"Ohira","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bja\/aeu016","article-title":"Burst suppression-MAC and burst suppression-CP(5)(0) as measures of cerebral effects of anaesthetics","volume":"112","author":"Pilge","year":"2014","journal-title":"Br. J. Anaesth"},{"key":"B64","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/yct.0000000000000093","article-title":"Propofol for ECT anesthesia a review of the literature","volume":"30","author":"Rasmussen","year":"2014","journal-title":"J. ECT"},{"key":"B65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nlm.2018.06.013","article-title":"Anesthetics alleviate learning and memory impairment induced by electroconvulsive shock by regulation of NMDA receptor-mediated metaplasticity in depressive rats","volume":"155","author":"Ren","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12871-025-03087-x","article-title":"Dexmedetomidine for chronic pain patients with anxiety and depression: a propensity score matching cohort study","volume":"25","author":"Ren","year":"2025","journal-title":"BMC Anesthesiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpsychires.2024.01.031","article-title":"Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis","volume":"171","author":"Ren","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamapsychiatry.2022.3352","article-title":"Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: A systematic review and meta-analysis","volume":"79","author":"Rhee","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41380-023-02366-8","article-title":"Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis","volume":"29","author":"Rhee","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41386-019-0411-y","article-title":"Sleep, insomnia, and depression","volume":"45","author":"Riemann","year":"2020","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/ALN.0b013e31823d0c36","article-title":"An allosteric coagonist model for propofol effects on alpha1beta2gamma2L gamma-aminobutyric acid type A receptors","volume":"116","author":"Ruesch","year":"2012","journal-title":"Anesthesiology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/foc.6.1.foc128","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/bf02479866","article-title":"Effects of total intravenous anesthesia with propofol on immuno-endocrine changes during surgical stress","volume":"9","author":"Sakai","year":"1995","journal-title":"J. Anesth."},{"key":"B75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/npp.2014.261","article-title":"Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders","volume":"40","author":"Sanacora","year":"2015","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12871-018-0632-3","article-title":"Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis","volume":"18","author":"Schraag","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.injury.2013.05.004","article-title":"Propofol infusion syndrome: a lethal condition in critically injured patients eliminated by a simple screening protocol","volume":"45","author":"Schroeppel","year":"2014","journal-title":"Injury"},{"key":"B78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s40001-025-02509-3","article-title":"Dexmedetomidine for modified electroconvulsive therapy: a dose-optimized treatment study","volume":"30","author":"Shen","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","article-title":"Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression","volume":"155","author":"Shiroma","year":"2014","journal-title":"J. Affect Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/aln.0000000000006042","article-title":"Effects of single bolus exposure to propofol on depression-like behavior in a chronic unpredictable mild stress model in mice","volume":"144","author":"Song","year":"2026","journal-title":"Anesthesiology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/aco.0000000000000617","article-title":"Emerging evidence for antidepressant actions of anesthetic agents","volume":"31","author":"Tadler","year":"2018","journal-title":"Curr. Opin. Anaesthesiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0929867003375335","article-title":"Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery","volume":"7","author":"Trapani","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4097\/kja.24707","article-title":"A comprehensive analysis of propofol abuse, addiction and neuropharmacological aspects: an updated review","volume":"78","author":"Uzbay","year":"2025","journal-title":"Korean J. Anesthesiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","article-title":"The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome","volume":"29","author":"Vasile","year":"2003","journal-title":"Intensive Care Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1601-5215.2011.00610.x","article-title":"Assessment of the hypothalamic-pituitary-adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress - a systematic review","volume":"24","author":"Von Werne Baes","year":"2012","journal-title":"Acta Neuropsychiatr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00008506-200104000-00005","article-title":"Propofol [correction of propfol] versus methohexital for electroconvulsive therapy: a meta-analysis","volume":"13","author":"Walder","year":"2001","journal-title":"J. Neurosurg. Anesthesiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/15563651003757954","article-title":"The abuse potential of propofol","volume":"48","author":"Wilson","year":"2010","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0304-3940(03)00611-6","article-title":"Evidence of association between gamma-aminobutyric acid type A receptor genes located on 5q34 and female patients with mood disorders","volume":"349","author":"Yamada","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309059","article-title":"Propofol alleviates anxiety-like behaviors associated with pain by inhibiting the hyperactivity of PVN(CRH) neurons via GABA(A) receptor beta3 subunits","volume":"11","author":"Yu","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"113380","DOI":"10.1016\/j.bbr.2021.113380","article-title":"Effects of propofol on sleep architecture and sleep-wake systems in rats","volume":"411","author":"Yue","year":"2021","journal-title":"Behav. Brain Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/00000542-199205000-00006","article-title":"Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers","volume":"76","author":"Zacny","year":"1992","journal-title":"Anesthesiology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jad.2024.09.038","article-title":"Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: a randomized, double-blind, controlled, non-inferiority trial","volume":"368","author":"Zeng","year":"2025","journal-title":"J. Affect Disord."},{"key":"B95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2016.03.020","article-title":"Propofol alleviates electroconvulsive shock-induced memory impairment by modulating proBDNF\/mBDNF ratio in depressive rats","volume":"1642","author":"Zhang","year":"2016","journal-title":"Brain Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1007\/s00213-019-05287-z","article-title":"Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice","volume":"236","author":"Zhang","year":"2019","journal-title":"Psychopharmacol. (Berl)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.neuron.2023.02.017","article-title":"Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter","volume":"111","author":"Zhu","year":"2023","journal-title":"Neuron"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1876988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:44:24Z","timestamp":1786365864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1876988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":97,"alternative-id":["10.3389\/fphys.2026.1876988"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2026.1876988","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1876988"}}